---
title: "ZHEJIANG ZHENGTE: Expected net profit in the first half of the year to increase by 33.40%-80.49% year-on-year"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/248373664.md"
description: "ZHEJIANG ZHENGTE announced that it expects a net profit of 60.28 million to 81.56 million yuan in the first half of 2025, an increase of 33.40% to 80.49% compared to 45.1881 million yuan in the same period last year"
datetime: "2025-07-14T08:43:21.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/248373664.md)
  - [en](https://longbridge.com/en/news/248373664.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/248373664.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/248373664.md) | [繁體中文](https://longbridge.com/zh-HK/news/248373664.md)


# ZHEJIANG ZHENGTE: Expected net profit in the first half of the year to increase by 33.40%-80.49% year-on-year

ZHEJIANG ZHENGTE announced that it expects a net profit of 60.28 million to 81.56 million yuan in the first half of 2025, an increase of 33.40% to 80.49% compared to 45.1881 million yuan in the same period last year

### 相关股票

- [ZHEJIANG ZHENGTE (001238.CN)](https://longbridge.com/zh-CN/quote/001238.CN.md)

## 相关资讯与研究

- [Tesla Shanghai Factory February Deliveries Nearly Double Year-on-Year. Can Demand Resilience Help It Regain Electric Vehicle Dominance?](https://longbridge.com/zh-CN/news/278719041.md)
- [US 10-Year High Yield 4.217% vs 4.177% Previous; Bid/Cover 2.45 vs 2.39 Previous](https://longbridge.com/zh-CN/news/278759161.md)
- [Fosun Pharma Unit Gets China Nod for Hematological Malignancy Drug Trial](https://longbridge.com/zh-CN/news/279052280.md)
- [Delpha Construction says 2025 net profit at T$1.70 bln](https://longbridge.com/zh-CN/news/278861800.md)
- [Intel announces new Intel Core Ultra 200S Plus series desktop processors](https://longbridge.com/zh-CN/news/278756604.md)